Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults

Clinical trial NCT04882085 · COMPLETED

Trial details

NCT number: NCT04882085
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Urinary Tract Infection Acute Pyelonephritis Hospital Acquired Pneumonia Ventilator-associated Pneumonia Bacteremia Intra-abdominal Infection

Start date: 2021-08-26
Primary completion: 2023-08-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.